| scholarly article | Q13442814 |
| P50 | author | Wei-Hua Jia | Q91676057 |
| P2093 | author name string | Li Zhang | |
| Xi Chen | |||
| Na Li | |||
| Guan-Hua Du | |||
| Lin Yin | |||
| Bi-Yu Hou | |||
| Xiu-Ying Yang | |||
| Chun-Yang Xu | |||
| Gui-Fen Qiang | |||
| Nuo-Qi Wang | |||
| P2860 | cites work | Insulin-stimulated glucose uptake in skeletal muscle, adipose tissue and liver: a positron emission tomography study. | Q51763477 |
| Genetic and pharmacological manipulation of urotensin II ameliorate the metabolic and atherosclerosis sequalae in mice. | Q54502525 | ||
| Elevated plasma levels of immunoreactive urotensin II and its increased urinary excretion in patients with Type 2 diabetes mellitus: association with progress of diabetic nephropathy | Q60713420 | ||
| Both somatostatin and the caudal neuropeptide, urotensin II, stimulate lipid mobilization from coho salmon liver incubated in vitro | Q68972603 | ||
| Effects of somatostatin-25 and urotensin II on lipid and carbohydrate metabolism of coho salmon, Oncorhynchus kisutch | Q69902865 | ||
| Interorgan Metabolic Crosstalk in Human Insulin Resistance | Q88691584 | ||
| The relationship between urotensin II and insulin resistance in women with gestational diabetes mellitus | Q93337984 | ||
| Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 | Q22010575 | ||
| Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord | Q24656200 | ||
| Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction | Q28137875 | ||
| A reference preparation for the study of active substances in the caudal neurosecretory system of teleosts | Q28252109 | ||
| International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, urotensin II-related peptide, and their receptor: from structure to function | Q28254485 | ||
| The obesity-induced transcriptional regulator TRIP-Br2 mediates visceral fat endoplasmic reticulum stress-induced inflammation | Q28834050 | ||
| Dynamics of fat cell turnover in humans | Q29615688 | ||
| C2C12 murine myoblasts as a model of skeletal muscle development: morpho-functional characterization. | Q31135850 | ||
| The G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features | Q33599835 | ||
| Regulation of lipid mobilization and oxidation during exercise in obesity | Q34157825 | ||
| Lipolysis: more than just a lipase | Q35156219 | ||
| Urotensin II: the old kid in town. | Q35756527 | ||
| Comparative understanding of UTS2 and UTS2R genes for their involvement in type 2 diabetes mellitus | Q36609389 | ||
| Uncoupling protein-3: clues in an ongoing mitochondrial mystery. | Q36698779 | ||
| Endogenous and Synthetic ABHD5 Ligands Regulate ABHD5-Perilipin Interactions and Lipolysis in Fat and Muscle | Q36886505 | ||
| Urotensin II-induced insulin resistance is mediated by NADPH oxidase-derived reactive oxygen species in HepG2 cells | Q37063375 | ||
| Blocking the urotensin II receptor pathway ameliorates the metabolic syndrome and improves cardiac function in obese mice | Q38310714 | ||
| Tumor Necrosis Factor-α Promotes Phosphoinositide 3-Kinase Enhancer A and AMP-Activated Protein Kinase Interaction to Suppress Lipid Oxidation in Skeletal Muscle | Q38839545 | ||
| Antidiabetic Effect of Salvianolic Acid A on Diabetic Animal Models via AMPK Activation and Mitochondrial Regulation. | Q38875773 | ||
| Metabolic Flexibility in Health and Disease | Q39280816 | ||
| Induction of thermogenic adipocytes: molecular targets and thermogenic small molecules | Q39419507 | ||
| Deletion of the UT receptor gene results in the selective loss of urotensin-II contractile activity in aortae isolated from UT receptor knockout mice | Q42215972 | ||
| Behavioral effects of urotensin-II centrally administered in mice | Q42667921 | ||
| Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype | Q43288560 | ||
| Inhibition of insulin release by urotensin II--a study on the perfused rat pancreas | Q43676795 | ||
| Pathways for glucose disposal after meal ingestion in humans | Q44244726 | ||
| Increased plasma urotensin II levels in patients with diabetes mellitus | Q44272734 | ||
| Elevated expression of urotensin II and its receptor in skeletal muscle of diabetic mouse | Q46073321 | ||
| Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice | Q46354910 | ||
| Cardiac actions of central but not peripheral urotensin II are prevented by beta-adrenoceptor blockade | Q46539844 | ||
| The urotensin-II receptor antagonist palosuran improves pancreatic and renal function in diabetic rats | Q46788574 | ||
| Intracerebroventricular administration of urotensin II regulates food intake and sympathetic nerve activity in brown adipose tissue | Q48610594 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 453 | |
| P577 | publication date | 2019-07-12 | |
| P1433 | published in | Frontiers in Endocrinology | Q27723680 |
| P1476 | title | Chronic Urotensin-II Administration Improves Whole-Body Glucose Tolerance in High-Fat Diet-Fed Mice | |
| P478 | volume | 10 |
Search more.